from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3824c/papA1

LFCtreatmentdescriptionclass of inhibitor

-1.170

Amikacinug/mL Amikacintranslation

-0.690

Cap5-10ug/mL Capreomycintranslation

-0.827

Rox10-50 ug/mL Roxithromycintranslation

-1.027

SM2-5 ug/mL Streptomycintranslation

-1.668

Tet5-10 ug/mL Tetracyclinetranslation

0.245

Rif0.2-5ug/mL Rifampicintranscription

0.501

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.126

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.789

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.823

CPZ10-50 ug/mL Chlorpromazinerespiration

0.378

Clofazimine10-13 ug/mL Clofaziminerespiration

0.146

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.758

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.523

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.168

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.177

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.087

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.456

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.366

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.027

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.843

KCN5-20 ug/mL Potassium cyaniderespiration

-0.328

NaN30.2-2 mM Sodium aziderespiration

0.152

Nigericin50 uM Nigericinrespiration

-0.316

TRC10-150 ug/mL Triclosanrespiration

0.367

TRZ10-25 ug/mL Thioridazinerespiration

-1.592

Valinomycin0.5-10 uM Valinomycinrespiration

1.989

ZnSO42 mM ZnSO4respiration

-0.470

menadione6-10 ug/mL Menadionerespiration

0.910

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.178

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.216

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.518

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.942

NRP_1Non-replicating persistence stage 1dosRassociated

0.050

Amp0.2mg/mL AmpicillincellWall

0.095

Cephalexin20-100 ug/mL CephalexincellWall

-0.440

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.072

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.034

EMB10-20 ug/mL EthambutolcellWall

-0.481

Eta12-40 ug/mL EthionamidecellWall

-0.536

INH0.2-0.4 ug/mL IsoniazidcellWall

1.653

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.212

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.047

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.335

BZA0.12 mg/mL BenzamidearomaticAmides

-0.756

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.791

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.325

H2O24 mM hydrogen peroxideDNAdamaging

0.186

Levo10 ug/mL LevofloxacinDNAdamaging

0.281

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.873

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.542

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.465

UVUV-irradiationDNAdamaging

-0.530

ARP41-4 ug/mL Antitubercular compound ARP4?

1.058

Antimycin12.5-50 ug/mL Antimycin A?

0.579

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.353

PA_110-50 ug/mL Antitubercular compound PA-1?

0.308

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.853

PA8240.2-2 ug/mL PA-824?

-1.802

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.521

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.045

Verapamil50 uM Verapamil?

0.722

mercaptoethanol2 mM 2-Mercaptoethanol?

0.196

methoxatin10-20 ug/mL Methoxatin?